HTA Archives - Pharmaphorum

The shadow of Brexit on speed of access

https://pharmaphorum.com/views-analysis-market-access/the-shadow-of-brexit-on-speed-of-access/

Access to new medicines in Scotland: a perennial issue

https://pharmaphorum.com/views-and-analysis/access-to-new-medicines-in-scotland-a-perennial-issue/

Mandatory or voluntary? A sticking point for European HTA

https://pharmaphorum.com/views-analysis-market-access/mandatory-or-voluntary-a-sticking-point-for-european-hta/

Only 4 Weeks Until Orphan Drugs & Rare Diseases 2018

https://pharmaphorum.com/partner-content/only-4-weeks-until-orphan-drugs-rare-diseases-2018/

Realising the biotech promise: addressing the path to market

https://pharmaphorum.com/market-access-2/addressing-the-path-to-market/

Division on European HTA

https://pharmaphorum.com/views-and-analysis/hta-european-health-technology-assessment-division-progress/

Who should pay for HTA?

https://pharmaphorum.com/views-analysis-digital/who-should-pay-hta/

Resourcing HTA across Europe

https://pharmaphorum.com/views-analysis-market-access/resourcing-hta-across-europe/

Harmonised health technology assessment in Europe? There’s a long way to go

https://pharmaphorum.com/views-analysis-market-access/harmonised-health-technology-assessment-in-europe-theres-a-long-way-to-go/

Search